Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 06:38:11 UTC |
---|
Update Date | 2022-11-23 21:54:22 UTC |
---|
HMDB ID | HMDB0249775 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Cefroxadine |
---|
Description | 7-{[2-amino-2-(cyclohexa-1,4-dien-1-yl)-1-hydroxyethylidene]amino}-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid belongs to the class of organic compounds known as cephalosporins. Cephalosporins are compounds containing a 1,2-thiazine fused to a 2-azetidinone to for a oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid moiety or a derivative thereof. Based on a literature review a significant number of articles have been published on 7-{[2-amino-2-(cyclohexa-1,4-dien-1-yl)-1-hydroxyethylidene]amino}-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). Cefroxadine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Cefroxadine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | COC1=C(N2C(SC1)C(NC(=O)C(N)C1=CCC=CC1)C2=O)C(O)=O InChI=1S/C16H19N3O5S/c1-24-9-7-25-15-11(14(21)19(15)12(9)16(22)23)18-13(20)10(17)8-5-3-2-4-6-8/h2-3,6,10-11,15H,4-5,7,17H2,1H3,(H,18,20)(H,22,23) |
---|
Synonyms | Value | Source |
---|
7-{[2-amino-2-(cyclohexa-1,4-dien-1-yl)-1-hydroxyethylidene]amino}-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | Generator |
|
---|
Chemical Formula | C16H19N3O5S |
---|
Average Molecular Weight | 365.4 |
---|
Monoisotopic Molecular Weight | 365.104541898 |
---|
IUPAC Name | 7-[2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
---|
Traditional Name | 7-[2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | COC1=C(N2C(SC1)C(NC(=O)C(N)C1=CCC=CC1)C2=O)C(O)=O |
---|
InChI Identifier | InChI=1S/C16H19N3O5S/c1-24-9-7-25-15-11(14(21)19(15)12(9)16(22)23)18-13(20)10(17)8-5-3-2-4-6-8/h2-3,6,10-11,15H,4-5,7,17H2,1H3,(H,18,20)(H,22,23) |
---|
InChI Key | RDMOROXKXONCAL-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cephalosporins. Cephalosporins are compounds containing a 1,2-thiazine fused to a 2-azetidinone to for a oxo-5-thia-1-azabicyclo[4.2.0]Oct-2-ene-2-carboxylic acid moiety or a derivative thereof. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Lactams |
---|
Sub Class | Beta lactams |
---|
Direct Parent | Cephalosporins |
---|
Alternative Parents | |
---|
Substituents | - Cephalosporin
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Meta-thiazine
- Vinylogous ester
- Tertiary carboxylic acid amide
- Amino acid or derivatives
- Amino acid
- Azetidine
- Carboxamide group
- Secondary carboxylic acid amide
- Thioether
- Hemithioaminal
- Carboxylic acid derivative
- Carboxylic acid
- Dialkylthioether
- Monocarboxylic acid or derivatives
- Azacycle
- Organic nitrogen compound
- Primary aliphatic amine
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Amine
- Organopnictogen compound
- Organic oxygen compound
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
cefroxadine,2TMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(NC(=O)C(N[Si](C)(C)C)C3=CCC=CC3)C2SC1 | 3046.1 | Semi standard non polar | 33892256 | cefroxadine,2TMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(NC(=O)C(N[Si](C)(C)C)C3=CCC=CC3)C2SC1 | 2744.9 | Standard non polar | 33892256 | cefroxadine,2TMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(NC(=O)C(N[Si](C)(C)C)C3=CCC=CC3)C2SC1 | 4538.6 | Standard polar | 33892256 | cefroxadine,2TMS,isomer #2 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(N)C3=CCC=CC3)[Si](C)(C)C)C2SC1 | 2878.6 | Semi standard non polar | 33892256 | cefroxadine,2TMS,isomer #2 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(N)C3=CCC=CC3)[Si](C)(C)C)C2SC1 | 2741.3 | Standard non polar | 33892256 | cefroxadine,2TMS,isomer #2 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(N)C3=CCC=CC3)[Si](C)(C)C)C2SC1 | 4891.7 | Standard polar | 33892256 | cefroxadine,2TMS,isomer #3 | COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C)C3=CCC=CC3)[Si](C)(C)C)C2SC1 | 2962.2 | Semi standard non polar | 33892256 | cefroxadine,2TMS,isomer #3 | COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C)C3=CCC=CC3)[Si](C)(C)C)C2SC1 | 2764.7 | Standard non polar | 33892256 | cefroxadine,2TMS,isomer #3 | COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C)C3=CCC=CC3)[Si](C)(C)C)C2SC1 | 4270.5 | Standard polar | 33892256 | cefroxadine,2TMS,isomer #4 | COC1=C(C(=O)O)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)C2SC1 | 3111.9 | Semi standard non polar | 33892256 | cefroxadine,2TMS,isomer #4 | COC1=C(C(=O)O)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)C2SC1 | 2817.9 | Standard non polar | 33892256 | cefroxadine,2TMS,isomer #4 | COC1=C(C(=O)O)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)C2SC1 | 4472.8 | Standard polar | 33892256 | cefroxadine,3TMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C)C3=CCC=CC3)[Si](C)(C)C)C2SC1 | 2937.6 | Semi standard non polar | 33892256 | cefroxadine,3TMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C)C3=CCC=CC3)[Si](C)(C)C)C2SC1 | 2806.2 | Standard non polar | 33892256 | cefroxadine,3TMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C)C3=CCC=CC3)[Si](C)(C)C)C2SC1 | 4060.4 | Standard polar | 33892256 | cefroxadine,3TMS,isomer #2 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)C2SC1 | 3061.7 | Semi standard non polar | 33892256 | cefroxadine,3TMS,isomer #2 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)C2SC1 | 2832.7 | Standard non polar | 33892256 | cefroxadine,3TMS,isomer #2 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)C2SC1 | 4314.5 | Standard polar | 33892256 | cefroxadine,3TMS,isomer #3 | COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C2SC1 | 3017.8 | Semi standard non polar | 33892256 | cefroxadine,3TMS,isomer #3 | COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C2SC1 | 2845.6 | Standard non polar | 33892256 | cefroxadine,3TMS,isomer #3 | COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C2SC1 | 4068.1 | Standard polar | 33892256 | cefroxadine,4TMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C2SC1 | 3026.4 | Semi standard non polar | 33892256 | cefroxadine,4TMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C2SC1 | 2871.4 | Standard non polar | 33892256 | cefroxadine,4TMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C2SC1 | 3854.4 | Standard polar | 33892256 | cefroxadine,2TBDMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(NC(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)C2SC1 | 3391.1 | Semi standard non polar | 33892256 | cefroxadine,2TBDMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(NC(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)C2SC1 | 3036.9 | Standard non polar | 33892256 | cefroxadine,2TBDMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(NC(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)C2SC1 | 4579.8 | Standard polar | 33892256 | cefroxadine,2TBDMS,isomer #2 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(N)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC1 | 3270.4 | Semi standard non polar | 33892256 | cefroxadine,2TBDMS,isomer #2 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(N)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC1 | 3030.0 | Standard non polar | 33892256 | cefroxadine,2TBDMS,isomer #2 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(N)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC1 | 4864.4 | Standard polar | 33892256 | cefroxadine,2TBDMS,isomer #3 | COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC1 | 3332.4 | Semi standard non polar | 33892256 | cefroxadine,2TBDMS,isomer #3 | COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC1 | 3053.4 | Standard non polar | 33892256 | cefroxadine,2TBDMS,isomer #3 | COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC1 | 4325.7 | Standard polar | 33892256 | cefroxadine,2TBDMS,isomer #4 | COC1=C(C(=O)O)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC1 | 3445.3 | Semi standard non polar | 33892256 | cefroxadine,2TBDMS,isomer #4 | COC1=C(C(=O)O)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC1 | 3070.9 | Standard non polar | 33892256 | cefroxadine,2TBDMS,isomer #4 | COC1=C(C(=O)O)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC1 | 4473.5 | Standard polar | 33892256 | cefroxadine,3TBDMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC1 | 3467.9 | Semi standard non polar | 33892256 | cefroxadine,3TBDMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC1 | 3228.3 | Standard non polar | 33892256 | cefroxadine,3TBDMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC1 | 4186.7 | Standard polar | 33892256 | cefroxadine,3TBDMS,isomer #2 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC1 | 3600.0 | Semi standard non polar | 33892256 | cefroxadine,3TBDMS,isomer #2 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC1 | 3233.0 | Standard non polar | 33892256 | cefroxadine,3TBDMS,isomer #2 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC1 | 4374.7 | Standard polar | 33892256 | cefroxadine,3TBDMS,isomer #3 | COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC1 | 3556.6 | Semi standard non polar | 33892256 | cefroxadine,3TBDMS,isomer #3 | COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC1 | 3248.2 | Standard non polar | 33892256 | cefroxadine,3TBDMS,isomer #3 | COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC1 | 4173.7 | Standard polar | 33892256 | cefroxadine,4TBDMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC1 | 3723.7 | Semi standard non polar | 33892256 | cefroxadine,4TBDMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC1 | 3430.8 | Standard non polar | 33892256 | cefroxadine,4TBDMS,isomer #1 | COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC1 | 3991.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Cefroxadine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-2900000000-03a6b71e5f2f34be381d | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cefroxadine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cefroxadine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cefroxadine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cefroxadine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cefroxadine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cefroxadine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cefroxadine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cefroxadine 10V, Positive-QTOF | splash10-0002-0029000000-2bfd58a12e28b55838fe | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cefroxadine 20V, Positive-QTOF | splash10-05cs-2945000000-30ce25f1b408b240d077 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cefroxadine 40V, Positive-QTOF | splash10-052f-9712000000-9da604c51c7f54c4e269 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cefroxadine 10V, Negative-QTOF | splash10-001i-0009000000-94f9c3f283ae621e07ac | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cefroxadine 20V, Negative-QTOF | splash10-03yi-3579000000-1753fc96f4f631e623c4 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cefroxadine 40V, Negative-QTOF | splash10-0006-9710000000-4bc8608a15a151bc30e4 | 2021-10-12 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum |
|
---|